作者:
Zhang,L. [1]
;
McCabe,T. [2]
;
Condra,J.H. [3]
;
Ni,Y.G. [4]
;
Peterson,L.B. [5]
;
Wang,W. [6]
;
Strack,A.M. [7]
;
Wang,F. [8]
;
Pandit,S. ;
Hammond,H. ;
Wood,D. ;
Lewis,D. ;
Rosa,R. ;
Mendoza,V. ;
Cumiskey,A.M. ;
Johns,D.G. ;
Hansen,B.C. ;
Shen,X. ;
Geoghagen,N. ;
Jensen,K. ;
Zhu,L. ;
Wietecha,K. ;
Wisniewski,D. ;
Huang,L. ;
Zhao,J.Z. ;
Ernst,R. ;
Hampton,R. ;
Haytko,P. ;
Ansbro,F. ;
Chilewski,S. ;
Chin,J. ;
Mitnaul,L.J. ;
Pellacani,A. ;
Sparrow,C.P. ;
An,Z. ;
Strohl,W. ;
Hubbard,B. ;
Plump,A.S. ;
Blom,D. ;
Sitlani,A.
作者单位:
Department of GEM Target Validation, Merck Research Laboratories, Rahway, NJ 07065, United States
[1]
Department of Atherosclerosis, Merck Research Laboratories, Rahway, NJ 07065, United States
[2]
Department of In Vitro Sciences, Merck Research Laboratories, Rahway, NJ 07065, United States
[3]
Department of Preclinical DMPK, Merck Research Laboratories, West Point, PA 19486, United States
[4]
Departments of Internal Medicine and Pediatric, University of South Florida, Tampa, FL 33612
[5]
Department of Bioprocess and Bioanalytical, Merck Research Laboratories, West Point, PA 19486
[6]
Department of MBV and Early Biologics, Upper Gwynedd, PA 19454, United States
[7]
Department of Biologics Research, Merck Research Laboratories, West Point, PA 19486, United States
[8]
发布时间
2013-11-20